The purpose of this study is to see if vitamin B can treat mild hyperlactatemia (a higher
than normal level of lactate in the blood) in patients who take nucleoside reverse
transcriptase inhibitors (NRTIs).
Hyperlactatemia is a potentially life-threatening condition that can be associated with NRTI
therapy. A lack of vitamin B may be related to the development of hyperlactatemia. However,
no studies have been done to evaluate this. This study proposes that high doses of vitamin B
may bring elevated lactate levels back to normal among patients taking NRTIs.
Phase:
N/A
Details
Lead Sponsor:
National Institute of Allergy and Infectious Diseases (NIAID)